Navigation Links
Stem cells to treat lung disease in preterm infants
Date:2/5/2014

Cincinnati, OH, February 6, 2014 -- Advances in neonatal care for very preterm infants have greatly increased the chances of survival for these fragile infants. However, preterm infants have an increased risk of developing bronchopulmonary dysplasia (BPD), a serious lung disease, which is a major cause of death and lifelong complications. In a new study scheduled for publication in The Journal of Pediatrics, researchers evaluated the safety and feasibility of using stem cell therapies on very preterm infants to prevent or treat BPD.

Won Soon Park, MD, PhD, and colleagues from Samsung Medical Center and Biomedical Research Institute, Seoul, Republic of Korea, conducted a phase I, single-center trial of intratracheal transplantation of human umbilical cord blood-derived mesenchymal stem cells to nine very preterm infants (24-26 weeks gestational age) who were at high risk of developing BPD.

All patients who received the treatment tolerated the procedure well without any immediate serious adverse effects. Thirty-three percent of treated infants developed moderate BPD and none developed severe BPD, and 72 percent of a matched comparison group developed moderate or severe BPD. Another serious side effect of very preterm birth, retinopathy of prematurity requiring surgery, tended to occur less often in treated infants. Overall, all nine treated infants survived to discharge, and only three developed moderate BPD.

This phase I study suggests that intratracheal administration of mesenchymal stem cells is safe and feasible. According to Dr. Park, "These findings strongly suggest that phase II clinical trials are warranted to test the efficacy of mesencymal stem cell transplantation, which could lead to new therapies to prevent or cure BPD." Dr. Park and colleagues are currently conducting a long-term safety and follow-up study of these nine preterm infants (ClinicalTrials.gov: NCT01632475).


'/>"/>

Contact: Becky Lindeman
journal.pediatrics@cchmc.org
513-636-7140
Elsevier Health Sciences
Source:Eurekalert

Related biology news :

1. In vitro innovation: Testing nanomedicine with blood cells on a microchip
2. Researchers reverse some lung diseases in mice by coaxing production of healthy cells
3. Engineered virus is effective against triple negative breast cancer cells
4. Scientists discover that thyroid cancer cells become less aggressive in outer space
5. New method increases supply of embryonic stem cells
6. Long-lived breast stem cells could retain cancer legacy
7. FASEB announces 2014 Science Research Conference: Skeletal Muscle Satellite and Stem Cells
8. UT Austin engineer converts yeast cells into sweet crude biofuel
9. FAK helps tumor cells enter the bloodstream
10. Little but lethal -- small RNAs coordinate bacterial attack on epithelial cells
11. Harvard scientists control cells following transplantation, from the inside out
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2017)... , May 5, 2017 RAM ... announced a new breakthrough in biometric authentication based ... quantum mechanical properties to perform biometric authentication. These new ... semiconductor material created by Ram Group and its ... entertainment, transportation, supply chains and security. Ram Group ...
(Date:4/19/2017)... , April 19, 2017 ... its vendor landscape is marked by the presence of ... is however held by five major players - 3M ... these companies accounted for nearly 61% of the global ... leading companies in the global military biometrics market boast ...
(Date:4/17/2017)... , April 17, 2017 NXT-ID, Inc. ... company, announces the filing of its 2016 Annual Report on Form ... Exchange Commission. ... Form 10-K is available in the Investor Relations section of the ... on the SEC,s website at http://www.sec.gov . 2016 ...
Breaking Biology News(10 mins):
(Date:7/14/2017)... ... 2017 , ... Dr. Joshua Mondlick has introduced the LANAP® protocol to treat ... Perio, in the Phoenix area. Dr. Mondlick is at the forefront of the ... treatment to re-grow bone and with significantly less pain than traditional surgery options. , ...
(Date:7/14/2017)... , ... July 14, 2017 , ... ... for sample preparation of proteins to clean peptides for mass spectrometry (MS) analysis ... , The PreOmics iST Kit is based on proprietary technology that contains ...
(Date:7/13/2017)... ... 13, 2017 , ... Heritage Biologics is proud to announce ... leader in promoting healthcare quality through accreditation, certification and measurement. By achieving this ... and better patient outcomes. , ÔÇťAchieving URAC accreditation is a reflection of ...
(Date:7/13/2017)... Island, NY (PRWEB) , ... July 13, 2017 ... ... starting with only two spectrophotometer calibration standards. Blast forward seven years and ... covers photometric accuracy, holmium oxide for wavelength accuracy, and resolution testing. ...
Breaking Biology Technology: